HIV Citation List: August 3 - August 16, 2012

PubMed citations

1. Sphingopeptides: Dihydrosphingosine-based Fusion Inhibitors against Wild-type and Enfuvirtide-resistant HIV-1. Ashkenazi, A., M. Viard, L. Unger, R. Blumenthal, and Y. Shai. FASEB Journal, 2012. [Epub ahead of print]; PMID[22872679].

[PubMed]. HIV_0803-081612.

2. Selective Targeting of the Repressive Transcription Factors YY1 and cMyc to Disrupt Quiescent Human Immunodeficiency Viruses. Barton, K.M. and D.M. Margolis. AIDS Research and Human Retroviruses, 2012. [Epub ahead of print]; PMID[22866663].

[PubMed]. HIV_0803-081612.

3. The M-T Hook Structure Is Critical for Design of HIV-1 Fusion Inhibitors. Chong, H., X. Yao, J. Sun, Z. Qiu, M. Zhang, S. Waltersperger, M. Wang, S. Cui, and Y. He. The Journal of Biological Chemistry, 2012. [Epub ahead of print]; PMID[22879603].

[PubMed]. HIV_0803-081612.

4. Synthesis of Betulinic Acid Derivatives as Entry Inhibitors against HIV-1 and Bevirimat-resistant HIV-1 Variants. Dang, Z., K. Qian, P. Ho, L. Zhu, K.H. Lee, L. Huang, and C.H. Chen. Bioorganic & Medicinal Chemistry Letters, 2012. 22(16): p. 5190-5194. PMID[22818973].

[PubMed]. HIV_0803-081612.

5. Synthesis of Novel Mannoside Glycolipid Conjugates for Inhibition of HIV-1 Trans-infection. Dehuyser, L., E. Schaeffer, O. Chaloin, C.G. Mueller, R. Baati, and A. Wagner. Bioconjugate Chemistry, 2012. [Epub ahead of print]; PMID[22871093].

[PubMed]. HIV_0803-081612.

6. A Quantitative Measurement of Antiviral Activity of anti-HIV-1 Drugs against SIV Infection: Dose Response Curve Slope Strongly Influences Class-specific Inhibitory Potential. Deng, K., M.C. Zink, J.E. Clements, and R.F. Siliciano. Journal of Virology, 2012. [Epub ahead of print]; PMID[22875968].

[PubMed]. HIV_0803-081612.

7. The Application of Bioisosteres in Drug Design for Novel Drug Discovery: Focusing on Acid Protease Inhibitors. Hamada, Y. and Y. Kiso. Expert Opinion on Drug Discovery, 2012. [Epub ahead of print]; PMID[22873630].

[PubMed]. HIV_0803-081612.

8. Inhibitory Effects of Chloroquine on the Activation of Plasmacytoid Dendritic Cells in SIVmac239-Infected Chinese Rhesus Macaques. Ma, J.P., H.J. Xia, G.H. Zhang, J.B. Han, L.G. Zhang, and Y.T. Zheng. Cellular & Molecular Immunology, 2012. [Epub ahead of print]; PMID[22885523].

[PubMed]. HIV_0803-081612.

9. 3-Phenylcoumarins as Inhibitors of HIV-1 Replication. Olmedo, D., R. Sancho, L.M. Bedoya, J.L. Lopez-Perez, E. Del Olmo, E. Munoz, J. Alcami, M.P. Gupta, and A. San Feliciano. Molecules, 2012. 17(8): p. 9245-9257. PMID[22858844].

[PubMed]. HIV_0803-081612.

10. Stereoselective Synthesis and Antiviral Activity of Methyl-substituted Cyclosal-pronucleotides. Rios Morales, E.H., J. Balzarini, and C. Meier. Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22827702].

[PubMed]. HIV_0803-081612.

11. CXCR4 Chemokine Receptor Antagonists: Nickel(II) Complexes of Configurationally Restricted Macrocycles. Smith, R., D. Huskens, D. Daelemans, R.E. Mewis, C.D. Garcia, A.N. Cain, T.N. Freeman, C. Pannecouque, E.D. Clercq, D. Schols, T.J. Hubin, and S.J. Archibald. Dalton Transactions, 2012. [Epub ahead of print]; PMID[22892890].

[PubMed]. HIV_0803-081612.

12. A Ligand-based Approach for the in Silico Discovery of Multi-target Inhibitors for Proteins Associated with HIV Infection. Speck-Planche, A., V.V. Kleandrova, F. Luan, and M.N. Cordeiro. Molecular BioSystems, 2012. 8(8): p. 2188-2196. PMID[22688327].

[PubMed]. HIV_0803-081612.

13. Design, Synthesis, and Preclinical Evaluations of Novel 4-Substituted 1,5-diarylanilines as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Drug Candidates. Sun, L.Q., L. Zhu, K. Qian, B. Qin, L. Huang, C.H. Chen, K.H. Lee, and L. Xie. Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22856541].

[PubMed]. HIV_0803-081612.

14. Chemical Methods for Degradation of Target Proteins Using Designed Light-activatable Organic Molecules. Tanimoto, S., D. Takahashi, and K. Toshima. Chemical Communications, 2012. 48(62): p. 7659-7671. PMID[22739361].

[PubMed]. HIV_0803-081612.

15. The Activity of the Integrase Inhibitor Dolutegravir against HIV-1 Variants Isolated from Raltegravir-treated Adults. Underwood, M.R., B.A. Johns, A. Sato, J.N. Martin, S.G. Deeks, and T. Fujiwara. Journal of AcquiredImmune DeficiencySyndromes, 2012. [Epub ahead of print]; PMID[22878423].

[PubMed]. HIV_0803-081612.

16. Structural Basis of Potent and Broad HIV-1 Fusion Inhibitor Cp32m. Yao, X., H. Chong, C. Zhang, Z. Qiu, B. Qin, R. Han, S. Waltersperger, M. Wang, Y. He, and S. Cui. Journal of Biological Chemistry, 2012. 287(32): p. 26618-26629. [Epub ahead of print]; PMID[22679024].

[PubMed]. HIV_0803-081612.

ISI Web of Knowledge Citations

17. Synthesis and Antimicrobial Activity of New 1,2,3-Triazolopyrimidine Derivatives and Their Glycoside and Acyclic Nucleoside Analogs. El-Sayed, W.A., O.M. Ali, M.S. Faheem, I.F. Zied, and A.A.H. Abdel-Rahman. Journal of Heterocyclic Chemistry, 2012. 49(3): p. 607-612. ISI[000306312700022].

[WOS]. HIV_0803-081612.

18. Synthesis and Characterization Via Molecular Quantum Parameters of 2H-Thiazolo 3,2-a pyrimidine-3,5,7(6h)-trione. Hamama, W.S., M.A. Ismail, M.S. Soliman, S. Shaaban, and H.H. Zoorob. Journal of Heterocyclic Chemistry, 2012. 49(3): p. 494-498. ISI[000306312700003].

[WOS]. HIV_0803-081612.

19. 15-Deoxy-delta(12,14)-prostaglandin J(2) Inhibits Human Immunodeficiency Virus-1 Tat-induced Monocyte Chemoattractant Protein-1/CCL2 Production by Blocking the Extracellular Signal-regulated Kinase-1/2 Signaling Pathway Independently of Peroxisome Proliferator-activated Receptor-γ and Heme Oxygenase-1 in Rat Hippocampal Slices. Kim, S.E., E.O. Lee, J.H. Yang, J.H.L. Kang, Y.H. Su, and Y.H. Chong. Journal of Neuroscience Research, 2012. 90(9): p. 1732-1742. ISI[000306272100006].

[WOS]. HIV_0803-081612.

20. Highly Concise and Stereoselective Total Synthesis of (5R,7S)-Kurzilactone. Mohapatra, D.K., P. Karthik, and J.S. Yadav. Helvetica Chimica Acta, 2012. 95(7): p. 1226-1230. ISI[000306277000023].

[WOS]. HIV_0803-081612.

21. Cytotoxic and anti-HIV Phenanthroindolizidine Alkaloids from Cryptocarya chinensis. Wu, T.S., C.R. Su, and K.H. Lee. Natural Product Communications, 2012. 7(6): p. 725-727. ISI[000305921300010].

[WOS]. HIV_0803-081612.

22. Quantitative Structure-Activity Relationship (QSAR) on New Substituted Thiazol-2-yliedene-benzamides as Potential anti-HIV Agents. Al-Masoudi, N.A., B. Salih, J. Jassim and A. Saeed. Journal of Computational and Theoretical Nanoscience, 2012. 9(5): p. 752-756. ISI[000306247400020].

[WOS]. HIV_0803-081612.

23. Rapid Catalyst Identification for the Synthesis of the Pyrimidinone Core of HIV Integrase Inhibitors. Bellomo, A., N. Celebi-Olcum, X.D. Bu, N. Rivera, R.T. Ruck, C.J. Welch, K.N. Houk, and S.D. Dreher. Angewandte Chemie, 2012. 51(28): p. 6912-6915. ISI[000305990800018].

[WOS]. HIV_0803-081612.

24. Diterpenes from Marine Brown Alga Dictyota guineensis (Dictyotaceae, Phaeophyceae). De-Paula, J.C., D.N. Cavalcanti, Y. Yoneshigue-Valentin, and V.L. Teixeira. Brazilian Journal of Pharmacognosy, 2012. 22(4): p. 736-740. ISI[000305981800005].

[WOS]. HIV_0803-081612.

25. Inhibitory Effect of a Brazilian Marine Brown Alga Spatoglossum schroederi on Biological Activities of Lachesis muta Snake Venom. Domingos, T.F.S., F.A. Ortiz-Ramirez, R.C. Villaca, D.N. Cavalcanti, E.F. Sanchez, V.L. Teixeira, and A.L. Fuly. Brazilian Journal of Pharmacognosy, 2012. 22(4): p. 741-747. ISI[000305981800006].

[WOS]. HIV_0803-081612.

26. Concise Synthesis of the anti-HIV Nucleoside EFdA. Kageyama, M., T. Miyagi, M. Yoshida, T. Nagasawa, H. Ohrui and H. Kuwahara. Bioscience Biotechnology and Biochemistry, 2012. 76(6): p. 1219-1225. ISI[000306151900027].

[WOS]. HIV_0803-081612.

27. Synthesis and Structure-Activity Relationship Studies of 1,3-Disubstituted 2-propanols as BACE-1 Inhibitors. Kumar, A.B., J.M. Anderson, A.L. Melendez and R. Manetsch. Bioorganic & Medicinal Chemistry Letters, 2012. 22(14): p. 4740-4744. ISI[000306101300049].

[WOS]. HIV_0803-081612.

28. HIV-1 Reverse Transcriptase: A Potential Target for Marine Products. Miceli, L.A., A.M.T. de Souza, C.R. Rodrigues, I.C.N.P. Paixao, V.L. Teixeira, and H.C. Castro. Brazilian Journal of Pharmacognosy, 2012. 22(4): p. 881-888. ISI[000305981800025].

[WOS]. HIV_0803-081612.

29. Synthesis of Nucleoside 5 '-Boranophosphorothioate Derivatives Using an H-Boranophosphonate monoester as a Precursor. Oka, N., Y. Takayama, K. Ando and T. Wada. Bioorganic & Medicinal Chemistry Letters, 2012. 22(14): p. 4571-4574. ISI[000306101300015].

[WOS]. HIV_0803-081612.

30. Antimicrobial, anti-TB, Anticancer and anti-HIV Evaluation of New S-Triazine-based Heterocycles. Patel, R.V., P. Kumari, D.P. Rajani, C. Pannecouque, E. De Clercq, and K.H. Chikhalia. Future Medicinal Chemistry, 2012. 4(9): p. 1053-1065. ISI[000306299600008].

[WOS]. HIV_0803-081612.

31. Solid-phase Microwave Assisted Synthesis of Curcumin Analogs. Pore, D., R. Alli, A.S.C. Prabhakar, R.R. Alavala, U. Kulandaivelu and S. Boyapati. Letters in Organic Chemistry, 2012. 9(6): p. 447-450. ISI[000306171900011].

[WOS]. HIV_0803-081612.

Latent HIV Reactivation

32. Reactivation of Latent HIV-1 by a Wide Variety of Butyric Acid-producing Bacteria. Imai, K., K. Yamada, M. Tamura, K. Ochiai and T. Okamoto. Cellular and Molecular Life Sciences, 2012. 69(15): p. 2583-2592. ISI[000306335000010].

[WOS]. HIV_0803-081612.